Correlation Between Cadrenal Therapeutics, and Coherus BioSciences
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Coherus BioSciences, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Coherus BioSciences.
Diversification Opportunities for Cadrenal Therapeutics, and Coherus BioSciences
-0.91 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cadrenal and Coherus is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Coherus BioSciences go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Coherus BioSciences
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to under-perform the Coherus BioSciences. But the stock apears to be less risky and, when comparing its historical volatility, Cadrenal Therapeutics, Common is 1.34 times less risky than Coherus BioSciences. The stock trades about -0.04 of its potential returns per unit of risk. The Coherus BioSciences is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 72.00 in Coherus BioSciences on August 28, 2024 and sell it today you would earn a total of 49.00 from holding Coherus BioSciences or generate 68.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Coherus BioSciences
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Coherus BioSciences |
Cadrenal Therapeutics, and Coherus BioSciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Coherus BioSciences
The main advantage of trading using opposite Cadrenal Therapeutics, and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. HCW Biologics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals |
| Coherus BioSciences vs. Assembly Biosciences | Coherus BioSciences vs. Spero Therapeutics | Coherus BioSciences vs. Achilles Therapeutics PLC | Coherus BioSciences vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |